Rare intranuclear inclusions in the brains of 3 older adult males with fragile X syndrome: Implications for the spectrum of fragile X-associated disorders

Journal of Neuropathology and Experimental Neurology

Volumn 70, Issue 6, 2011, Pages 462-469

  Hunsaker, Michael R ^a   Greco, Claudia M ^a,b   Tassone, Flora ^a,b   Berman, Robert F ^a   Willemsen, Rob ^c   Hagerman, Randi J ^a,b   Hagerman, Paul J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Autism; FMR1; Fragile X syndrome; FXTAS; Neurodegeneration; Parkinson

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA;

5' UNTRANSLATED REGION; ADULT; ARTICLE; CASE REPORT; CELL NUCLEUS INCLUSION BODY; CONTROLLED STUDY; DENTATE GYRUS; FMR1 GENE; FRAGILE X SYNDROME; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; NERVE DEGENERATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; BRAIN; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; INTRANUCLEAR INCLUSION BODIES; MALE; NEURONS; RNA, MESSENGER; TRINUCLEOTIDE REPEAT EXPANSION; UBIQUITIN;

EID: 79957468734     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e31821d3194     Document Type: Article

References (44)

1. Fu YH, Kuhl DP, Pizzuti A, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell 1991;67:1047-58 (Pubitemid 121001519)
2. Pieretti M, Zhang FP, Fu YH, et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 1991;66:817-22 (Pubitemid 121001715)
3. Verkerk AJMH, Pieretti M, Sutcliffe JS, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991;65: 905-14 (Pubitemid 121001321)
4. Snow K, Doud LK, Hagerman R, et al. Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet 1993;53:1217-28 (Pubitemid 23346220)
5. Chonchaiya W, Schneider A, Hagerman RJ. Fragile X: A family of disorders. Adv Pediatr 2009;56:165-86
6. Wittenberger MD, Hagerman RJ, Sherman SL, et al. The FMR1 pre-mutation and reproduction. Fertil Steril 2007;87:456-65
7. Chonchaiya W, Utari A, Pereira GM, et al. Broad clinical involvement in a family affected by the fragile X premutation. J Dev Behav Pediatr 2009;30:544-51
8. Coffey SM, Cook K, Tartaglia N, et al. Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A 2008;146A: 1009-16
9. Rodriguez-Revenga L, Gomez-Anson B, Munoz E, et al. FXTAS in Spanish patients with ataxia: Support for female FMR1 premutation screening. Mol Neurobiol 2007;35:324-28 (Pubitemid 350129694)
10. Rodriguez-Revenga L, Madrigal I, Pagonabarraga J, et al. Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families. Eur J Hum Genet 2009;17:1359-62
11. Rodriguez-Revenga L, Santos MM, Sanchez A, et al. Screening for FXTAS in 95 Spanish patients negative for Huntington disease. Genet Test 2008;12:135-39
12. Jacquemont S, Hagerman RJ, Leehey MA, et al. Penetrance of the fragile XYassociated tremor/ataxia syndrome in a premutation carrier population. JAMA 2004;291:460-69 (Pubitemid 38129750)
13. Bourgeois JA, Coffey SM, Rivera SM, et al. A review of fragile X pre-mutation disorders: Expanding the psychiatric perspective. J Clin Psychiatry 2009;70:852-62
14. Bourgeois JA, Cogswell JB, Hessl D, et al. Cognitive, anxiety and mood disorders in the fragile XYassociated tremor/ataxia syndrome. Gen Hosp Psychiatry 2007;29:349-56 (Pubitemid 46962689)
15. Bourgeois JA, Farzin F, Brunberg JA, et al. Dementia with mood symptoms in a fragile X premutation carrier with the fragile XYassociated tremor/ataxia syndrome: Clinical intervention with donepezil and venla-faxine. J Neuropsychiatry Clin Neurosci 2006;18:171-77
16. Bourgeois JA, Seritan AL, Casillas EM, et al. Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers. J Clin Psychiatry 2011;72:175-82
17. Chonchaiya W, Nguyen DV, Au J, et al. Clinical involvement in daughters of men with fragile XYassociated tremor/ataxia syndrome. Clin Genet 2010;78:39-46
18. Farzin F, Perry H, Hessl D, et al. Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X pre-mutation. J Dev Behav Pediatr 2006;27:S138-44
19. Chonchaiya W, Tassone F, Ashwood P, et al. Autoimmune disease in mothers with the FMR1 premutation is associated with seizures in their children with fragile X syndrome. Hum Genet 2010;128:540-48
20. Zhang L, Coffey S, Lua LL, et al. FMR1 premutation in females diagnosed with multiple sclerosis. J Neurol Neurosurg Psychiatry 2009;80:812-14
21. Greco CM, Tassone F, Garcia-Arocena D, et al. Clinical and neuro-pathologic findings in a woman with the FMR1 premutation and multiple sclerosis. Arch Neurol 2008;65:1114-16
22. Tassone F, Beilina A, Carosi C, et al. Elevated FMR1 mRNA in pre-mutation carriers is due to increased transcription. RNA 2007;13:555-62 (Pubitemid 46506938)
23. Tassone F, Hagerman PJ. Expression of the FMR1 gene. Cytogenet Genome Res 2003;100:124-28 (Pubitemid 37467798)
24. Tassone F, Hagerman RJ, Taylor AK, et al. Elevated levels of FMR1 mRNA in carrier males: A new mechanism of involvement in the fragile-X syndrome. Am J Hum Gen 2000;66:6-15 (Pubitemid 30481464)
25. Garcia-Arocena D, Hagerman PJ. Advances in understanding the molecular basis of FXTAS. Hum Mol Genet 2010;19:R83-89
26. Todd PK, Paulson HL. RNA-mediated neurodegeneration in repeat expansion disorders. Ann Neurol 2010;67:291-300
27. Sellier C, Rau F, Liu Y, et al. Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients. EMBO J 2010;29:1248-61
28. Greco CM, Berman RF, Martin RM, et al. Neuropathology of fragile XYassociated tremor/ataxia syndrome (FXTAS). Brain 2006;129:243-55 (Pubitemid 43063775)
29. Greco CM, Hagerman RJ, Tassone F, et al. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 2002;125:1760-71
30. Iwahashi CK, Yasui DH, An HJ, et al. Protein composition of the intranuclear inclusions of FXTAS. Brain 2006;129:256-71
31. Tassone F, Hagerman RJ, Garcia-Arocena D, et al. Intranuclear inclusions in neural cells with premutation alleles in fragile XYassociated tremor/ataxia syndrome. J Med Genet 2004;42:e43
32. Tassone F, Iwahashi C, Hagerman PJ. FMR1 RNA within the intranuclear inclusions of fragile XYassociated tremor/ataxia syndrome (FXTAS). RNA Biol 2004;1:103-5
33. Tassone F, Hagerman RJ, Loesch DZ, et al. Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. Am J Med Genet 2000;94:232-37
34. Tassone F, Hagerman RJ, Taylor AK, et al. A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1 messenger RNA. J Med Genet 2001;39:453-56 (Pubitemid 32661207)
35. Tassone F, Hagerman RJ, Chamberlain WD, et al. Transcription of the FMR1 gene in individuals with fragile X syndrome. Am J Med Genet 2000;97:195-203 (Pubitemid 32059207)
36. Nolin SL, Glicksman A, Houck GE Jr, et al. Mosaicism in fragile X affected males. Am J Med Genet 1994;51:509-12 (Pubitemid 24197736)
37. Greco, CM, Navarro CS, Hunsaker MR, et al. Neuropathological features in the hippocampus and cerebellum of three older men with fragile X syndrome. Mol Autism 2011;2:2
38. Filipovic-Sadic S, Sah S, Chen L, et al. A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome. Clin Chem 2010;56:409-18
39. Tassone F, Pan R, Amiri K, et al. A rapid polymerase chain reactionYbased screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. J Mol Diagn 2008;10: 43-49 (Pubitemid 351184834)
40. Iwahashi C, Tassone F, Hagerman RJ, et al. A quantitative ELISA assay for the fragile X mental retardation 1 protein. J Mol Diagn 2009;11: 281-89
41. Mientjes EJ, Nieuwenhuizen I, Kirkpatrick L, et al. The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo. Neurobiol Dis 2006;21:549-55 (Pubitemid 43277538)
42. Brouwer JR, Huizer K, Severijnen LA, et al. CGG-repeat length and neuropathological and molecular correlates in a mouse model for fragile XYassociated tremor/ataxia syndrome. J Neurochem 2008;107:1671-82
43. Entezam A, Biacsi R, Orrison B, et al. Regional FMRP deficits and large repeat expansions into the full mutation range in a new Fragile X premutation mouse model. Gene 2007;405:125-34 (Pubitemid 46670641)
44. Utari A, Adams E, Berry-Kravis E, et al. Aging in fragile X syndrome. J Neurodev Disord 2010;2:70-76